114 related articles for article (PubMed ID: 9679534)
1. The Dartmouth Regimen: gone or going strong?
McClay EF; Berd D; Mastrangelo MJ
Cancer Invest; 1998; 16(6):421-3. PubMed ID: 9679534
[No Abstract] [Full Text] [Related]
2. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.
Chapman PB; Einhorn LH; Meyers ML; Saxman S; Destro AN; Panageas KS; Begg CB; Agarwala SS; Schuchter LM; Ernstoff MS; Houghton AN; Kirkwood JM
J Clin Oncol; 1999 Sep; 17(9):2745-51. PubMed ID: 10561349
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
[No Abstract] [Full Text] [Related]
4. Systemic chemotherapy for the treatment of metastatic melanoma.
Li Y; McClay EF
Semin Oncol; 2002 Oct; 29(5):413-26. PubMed ID: 12407507
[TBL] [Abstract][Full Text] [Related]
5. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
Fierro MT; Bertero M; Novelli M; Appino A; Doveil GC; Colonna S; Bernengo MG
Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
[TBL] [Abstract][Full Text] [Related]
6. Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up.
Lattanzi SC; Tosteson T; Chertoff J; Maurer LH; O'Donnell J; LeMarbre PJ; Mott L; DelPrete SA; Forcier RJ; Ernstoff MS
Melanoma Res; 1995 Oct; 5(5):365-9. PubMed ID: 8541728
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of metastatic melanoma.
Berd D; Mastrangelo MJ
J Clin Oncol; 1995 Mar; 13(3):796-7. PubMed ID: 7884439
[No Abstract] [Full Text] [Related]
8. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
Rusthoven JJ; Quirt IC; Iscoe NA; McCulloch PB; James KW; Lohmann RC; Jensen J; Burdette-Radoux S; Bodurtha AJ; Silver HK; Verma S; Armitage GR; Zee B; Bennett K
J Clin Oncol; 1996 Jul; 14(7):2083-90. PubMed ID: 8683240
[TBL] [Abstract][Full Text] [Related]
9. Sustained complete remission after chemobiohormonal therapy for metastatic melanoma.
Stein ME; Bernstein Z; Drumea K; Zalik M; Shklar Z; Steiner M; Haim N
Am J Clin Oncol; 1999 Feb; 22(1):62-4. PubMed ID: 10025383
[TBL] [Abstract][Full Text] [Related]
10. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
[TBL] [Abstract][Full Text] [Related]
12. Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):65-9. PubMed ID: 1642409
[TBL] [Abstract][Full Text] [Related]
13. Chemohormone therapy of metastatic melanoma with megestrol acetate plus dacarbazine, carmustine, and cisplatin.
Nathanson L; Meelu MA; Losada R
Cancer; 1994 Jan; 73(1):98-102. PubMed ID: 8275444
[TBL] [Abstract][Full Text] [Related]
14. The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen.
Crowell EB; Higa GM
W V Med J; 1993 Jun; 89(6):233-5. PubMed ID: 8322461
[TBL] [Abstract][Full Text] [Related]
15. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
16. Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study.
Stein ME; Bernstein Z; Tsalic M; Drumea K; Steiner M; Sklar Z; Haim N
Am J Clin Oncol; 2002 Oct; 25(5):460-3. PubMed ID: 12393984
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
Tan EH; Ang PT
Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
[TBL] [Abstract][Full Text] [Related]
18. Three-drug combination of cisplatin, dacarbazine, and tamoxifen in metastatic malignant melanoma.
Chmielowska E; Potemski P; PluzaĆska A
J Clin Oncol; 1995 Aug; 13(8):2146-7. PubMed ID: 7636562
[No Abstract] [Full Text] [Related]
19. High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
Cocconi G
Cancer; 1992 Aug; 70(4):902. PubMed ID: 1643625
[No Abstract] [Full Text] [Related]
20. Tamoxifen: is it useful in the treatment of patients with metastatic melanoma?
McClay EF; McClay ME
J Clin Oncol; 1994 Mar; 12(3):617-26. PubMed ID: 8120562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]